Jan.2024, LBMM founds second startup TheraMe!
© 2024 EPFL
After founding the antibody discovery company Velabs Therapeutics in 2017 (now operating as Veraxa Biotech), LBMM now has a second spinoff: TheraMe! – a startup bringing microfluidic technology for personalized cancer therapy into the clinic.
For more details, please have a look at www.thera-me.ch. A big thanks to all LBMM co-founders and investors, without whom this would not have been possible!